[1]冯方方,吴 琼,鲁昌辉.清宫排毒汤治疗宫颈癌疗效及对患者肿瘤细胞上皮间质转化的影响[J].陕西中医,2021,(2):187-191.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.013]
　FENG Fangfang,WU Qiong,LU Changhui.Effect of Qinggong Paidu decoction on the treatment of cervical cancer and its impact on the epithelial-mesenchymal transformation of tumor cells[J].,2021,(2):187-191.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.013]
点击复制

清宫排毒汤治疗宫颈癌疗效及对患者肿瘤细胞上皮间质转化的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年2期
页码:
187-191
栏目:
临床研究
出版日期:
2021-02-05

文章信息/Info

Title:
Effect of Qinggong Paidu decoction on the treatment of cervical cancer and its impact on the epithelial-mesenchymal transformation of tumor cells
作者:
冯方方1; 吴 琼1 ; 鲁昌辉2
(1.湖北医药学院附属随州医院妇产科,湖北 随州 441300; 2.鄂州市中心医院中医科,湖北 鄂州 436000)
Author(s):
FENG Fangfang; WU Qiong; LU Changhui
(Department of Obstetrics and Gynecology,Suizhou Hospital Affiliated to Hubei Medical College,Suizhou 441300,China)
关键词:
宫颈癌;  上皮间质转化;  化疗;  清宫排毒汤;  辅助T细胞;  血清肿瘤标志物
Keywords:
Cervical cancer;  Epithelial-mesenchymal transformation;  Chemotherapy;  Qinggong Paidu decoction;  Helper T cells;  Serum tumor markers
分类号:
R 737.33
DOI:
DOI:10.3969/j.issn.1000-7369.2020.02.013
文献标志码:
A
摘要:
目的:观察清宫排毒汤治疗宫颈癌的疗效及其对患者肿瘤细胞上皮间质转化基因表达的影响。方法:选取108例宫颈癌患者纳入研究,将入选患者划分为常规组与治疗组,常规组给予单纯化学药物治疗(化疗),治疗组在化疗基础上应用清宫排毒汤治疗。治疗3个化疗周期后,比较两组临床疗效; 观察两组患者治疗前后中医症候积分,血清肿瘤标志物:癌胚抗原(CEA)、鳞状上皮细胞癌抗原(SCCA)、糖类抗原125(CA125),辅助T细胞(Th)1/Th2细胞因子:γ-干扰素(IFN-γ)、白细胞介素(IL)-4、IL-2、IL-6,上皮间质转化基因:Vimentin、N-cadherin、E-cadherin、α-catenin的mRNA表达量的变化情况; 统计两组治疗期间不良反应发生率。结果:治疗组总有效率为81.48%,常规组为62.96%,治疗组高于常规组(P<0.05); 治疗组整体疗效水平优于常规组(P<0.05)。宫颈癌组织中Vimentin、N-cadherin基因mRNA表达量均高于本组正常宫颈组织(均P<0.05),E-cadherin、α-catenin基因mRNA表达量均低于本组正常宫颈组织(均P<0.05); 治疗组Vimentin、N-cadherin基因mRNA表达量均低于常规组(均P<0.05),E-cadherin、α-catenin基因mRNA表达量均高于常规组(均P<0.05)。治疗前两组患者中医症候积分、血清肿瘤标志物水平、Th1/Th2细胞因子水平比较,差异无统计学意义(均P>0.05); 治疗后,两组患者中医症候积分,血清CEA、SCCA、CA125水平,IL-4、IL-6水平均较本组治疗前下降(均P<0.05),治疗组均低于常规组(均P<0.05); IFN-γ、IL-2较本组治疗前均升高(均P<0.05),治疗组均高于常规组(均P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:清宫排毒汤佐治宫颈癌可提高临床疗效,能够通过降低血清肿瘤标志物与调节Th1/Th2细胞因子表达发挥阻止或延缓肿瘤细胞上皮间质转化的作用。
Abstract:
Objective:To observe the curative effect of Qinggong Paidu decoction on the expression of epithelial-mesenchymal transformation gene in patients with cervical cancer.Methods:A total of 108 cases of cervical cancer patients were divided into the conventional treatment group and the treatment group.Patients in the conventional treatment group were given simple chemical drug therapy(chemotherapy),and those in the treatment group were administered with Qinggong Paidu decoction on the basis of chemotherapy.After 3 cycles of chemotherapy,the clinical efficacy of the two groups was compared.Furthermore,the traditional Chinese medicine(TCM)syndrome integral,serum tumor markers of carcinoembryonic antigen(CEA),squamous cell carcinoma antigen(SCCA),carbohydrate antigen 125(CA125),T helper cell(Th)1/Th2 cytokines,γ-interferon(IFN-γ),interleukin(IL)-4,IL-2,IL-6,epithelial mesenchymal transforming genes of Vimentin,N-cadherin,E-cadherin and α-catenin changes at mRNA expression levels were compared in the two groups of patients before and after treatment.In addition,the incidence of adverse reactions was calculated during treatment in the two groups.Results:The total effective rate was 81.48% in the treatment group and 62.96% in the conventional treatment group,and the treatment group was higher than the conventional treatment group(P<0.05).The overall efficacy of the treatment group was better than that of the conventional treatment group(P<0.05).The mRNA expression levels of Vimentin and N-cadherin genes in cervical cancer tissues were all higher than that in normal cervical tissues of this group(all P<0.05),while those of E-cadherin and α-catenin genes were all lower than that in normal cervical tissues of this group(all P<0.05).Besides,the mRNA expression levels of Vimentin and N-cadherin genes in the treatment group were lower than those in the conventional treatment group(all P<0.05),and those of E-cadherin and α-catenin genes were higher than those in the conventional treatment group(all P<0.05).There were no statistically significant differences in TCM syndrome scores,serum tumor markers,and Th1/Th2 cytokine levels between the two groups before treatment(P>0.05).After treatment,TCM syndrome scores,serum CEA,SCCA and CA125 levels,IL-4 and IL-6 levels in both groups were all lower than those before treatment(all P<0.05),and the treatment group was lower than the conventional treatment group(P<0.05).Furthermore,the levels of IFN-γ and IL-2 in the treatment group were higher than those in the conventional treatment group(all P<0.05).Besides,there was no statistical difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:The Qinggong Paidu decoction can improve the clinical efficacy for the treatment of cervical cancer and play a role in preventing or delaying epithelial-mesenchymal transformation of tumor cells by reducing serum tumor markers and regulating the expression of Th1/Th2 cytokines.

参考文献/References:

[1] 孙桂霞,李艳云,杨少琴.化湿解毒汤对高级别CIN高危型HPV感染者LEEP术后湿热下注证患者转归的影响[J].中国实验方剂学杂志,2017,23(16):182-187.
[2] 甘 露,刘 瑞,魏 明,等.绝经后妇女612例宫颈HPV感染与宫颈病变关系的临床研究[J].陕西医学杂志,2018,47(5):574-576.
[3] 常忠莲,盛晓滨,石新兰,等.桂枝茯苓汤辨证加味对晚期宫颈癌化学药物治疗患者的增效减毒作用[J].首都医科大学学报,2018,39(4):596-601.
[4] 张莹莹,靳莉莉,崔 婷.六君子汤对宫颈癌辅助放化疗患者免疫功能、癌因性疲乏与生活质量的影响[J].中华中医药学刊,2018,36(7):1721-1723.
[5] Sergio P,Lucia Z,Franco O.Revised FIGO staging for carcinoma of the vulva,cervix,and endometrium [J].Int J Gynaecol Obstet,2009,105(2):103-104.
[6] 李苑瑛.清热利湿益肾解毒汤治疗子宫颈上皮内瘤变疗效及对GDF-15、Wnt-11、LRP-6水平影响的机制研究[J].中华中医药学刊,2020,38(1):184-186.
[7] 宋晓婕,周艳艳,赵莉娜.加味八珍汤联合放化疗对中晚期宫颈癌疗效及对患者T细胞亚群水平、血清肿瘤标志物表达及生存期的影响[J].中国实验方剂学杂志,2018,24(4):174-179.
[8] 梅丽君.中药扶正祛瘀汤结合同步放化疗对宫颈癌术后临床疗效的影响[J].内蒙古中医药,2020,39(3):56-57.
[9] 毛 莉,史晓敏,李彩虹,等.解毒化瘀汤联合新辅助化疗对宫颈癌T细胞亚群和血清肿瘤标志物表达的影响[J].中华中医药学刊,2019,37(6):1529-1532.
[10] 孙丽莎,张 娟,王 虹.加减八珍汤联合放化疗治疗中晚期宫颈癌临床观察[J].光明中医,2020,35(7):1041-1042.
[11] 张淑娟,周应恩,克尤木?阿不来提.扶正祛瘀汤联合同步放化疗治疗宫颈癌术后患者疗效及对机体免疫功能的影响[J].现代中西医结合杂志,2017,26(26):2921-2923.
[12] 董建新,江春花,王 艳.加减八珍汤联合放化疗对中晚期宫颈癌患者疗效及对生存期影响[J].辽宁中医药大学学报,2017,19(8):128-130.
[13] 李 静,易旺云,刘园利,等.转录因子 Twist、Snail、Slug 与宫颈上皮内瘤变组织中细胞侵袭、上皮间质转化的关系探究[J].中国妇幼保健,2019,34(14):3331-3334.
[14] Li B,Shi H,Wang F,et al.Expression of E,P and N-cadher-in and its clinical significance in cervical squamous cell carcinoma and precancerous lesions [J].PLoS One,2016,11(5):e0155910.
[15] 郜智慧,王倩青.疏肝化郁解毒汤对子宫颈癌术后化疗的效果及对血清Th1/Th2水平的影响[J].中华中医药学刊,2020,38(6):240-243.
[16] 杨晓燕,王烈宏.三仙保宫汤联合顺铂、紫杉醇化疗治疗中晚期宫颈癌临床分析[J].中华中医药学刊,2018,36(8):1936-1939.
[17] 李彩萍.八珍汤加减治疗宫颈癌临床观察[J].光明中医,2019,34(7):1048-1050.
[18] 刘玉瑰,崔红英,刘丽霞.益肾通癃汤联合低频电刺激治疗宫颈癌术后尿潴留疗效及其安全性研究[J].陕西中医,2019,40(6):736-739.

相似文献/References:

[1]聂金霞,陈 难,邓克红.当归补血汤对宫颈癌荷瘤小鼠抑瘤效果及对免疫调节作用的研究*[J].陕西中医,2019,(3):279.
　NIE Jinxia,CHEN Nan,DENG Kehong..Experimental study on the antitumor effect and immune regulation of Danggui Buxue decoction on cervical cancer bearing mice[J].,2019,(2):279.
[2]徐东英,冯相珍.掌叶半夏有效提取物对宫颈癌大鼠癌组织中Survivin、Caspase-3及Caspase-7的影响[J].陕西中医,2019,(7):832.
　XU Dongying,FENG Xiangzhen..Effect of effective extract of Pinellia ternata on Survivin,Caspase -3 and Caspase -7 in carcinoma of cervical cancer rats[J].,2019,(2):832.
[3]孙立哲,李磊强△,耿翠翠,等.圣愈汤联合放射治疗对人宫颈癌荷瘤小鼠脾脏 DCs 细胞功能的影响*[J].陕西中医,2019,(9):1162.
　SUN Lizhe,LI Leiqiang,GENG Cuicui,et al.Effect of combined radiotherapy and Shengyu decoction treatment on function of splenic DCs in cancerbearing mice[J].,2019,(2):1162.
[4]陈十昔,赵 彦,韩宁宁,等.白头翁汤保留灌肠联合rhGMCSF治疗Ⅱ～Ⅲ期宫颈癌盆腔放疗〖JZ〗所致急性放射性直肠炎疗效及对患者炎症反应的影响*[J].陕西中医,2020,(1):46.
　CHEN Shixi,ZHAO Yan,HAN Ningning,et al.Effect of Baitouweng decoction retention enema combined with rhGMCSF on acute radiation 〖JZ〗proctitis caused by pelvic radiotherapy of stage Ⅱ～Ⅲ cervical cancer and its inflammatory response[J].,2020,(2):46.
[5]王小辉,刘紫玲△.贞芪扶正颗粒联合顺铂治疗中晚期宫颈癌术后疗效及对患者T淋巴细胞亚群影响*[J].陕西中医,2020,(6):736.[doi:DOI:10.3969/j.issn.10007369.2020.06.010]
　WANG Xiaohui,LIU Ziling..Application of Zhenqi Fuzheng granules combined with cisplatin regimen in middle and advanced stage cervical cancer after surgery and the influence on T lymphocyte subsets[J].,2020,(2):736.[doi:DOI:10.3969/j.issn.10007369.2020.06.010]
[6]郝志晔,张 晶,钱 伟,等.参芪排毒汤对宫颈癌组织人乳头瘤病毒E6/E7、P53和PRb基因蛋白表达的影响[J].陕西中医,2021,(2):192.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.014]
　HAO Zhiye,ZHANG Jing,QIAN Wei,et al.Effect and of Shenqi Paidu decoction on the expression of HPV E6/E7,P53 and PRb in cervical cancer tissues[J].,2021,(2):192.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.014]
[7]杨 繁,曾永蕾.苦参碱对宫颈癌细胞中Bcl-2/Bax表达水平及生物学行为的影响[J].陕西中医,2021,(7):840.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.006]
　YANG Fan,ZENG Yonglei.Effect of matrine on Bcl-2/Bax expression level and biological behavior in cervical cancer cells[J].,2021,(2):840.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.006]
[8]徐建立,孙艳华,李 明,等.紫草素通过抑制上皮间质转化缓解结肠癌细胞5-氟尿嘧啶耐药[J].陕西中医,2022,(3):296.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.006]
[9]吴艳芳,陈 蕾.八珍汤加味联合放疗治疗中晚期宫颈癌疗效及对患者细胞免疫水平和营养状态的影响[J].陕西中医,2022,(8):1052.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.015]
[10]骆小珊,谢 甦,朱曼荆,等.薯蓣丸联合紫杉醇抑制三阴性乳腺癌细胞MDA-MB-231上皮间质转化作用和机制研究[J].陕西中医,2023,(9):1163.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.001]
　LUO Xiaoshan,XIE Su,ZHU Manjing,et al.Effect and mechanism of Dioscorea pills combined with paclitaxel on epithelial-mesenchymal transition in triple-negative breast cancer MDA-MB-231 cells[J].,2023,(2):1163.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.001]

备注/Memo

备注/Memo:
基金项目:湖北省自然科学基金资助项目(2013FFB07643)
更新日期/Last Update: 2021-01-28